<DOC>
	<DOCNO>NCT00100620</DOCNO>
	<brief_summary>The intake high dos corticosteroid know play important role weaken bone thus increase fracture risk . Zoledronic acid ( Aclasta ) drug know protective effect bone disease ( tumor , paget ) . This study test safety efficacy zoledronic acid prevention treatment corticosteroid induce osteoporosis male female patient .</brief_summary>
	<brief_title>Efficacy Safety Zoledronic Acid Prevention Treatment Corticosteroid Induced Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Long duration treatment corticosteroid ( start ongoing ) History osteogenesis imperfecta , multiple myeloma Paget 's disease History Hyperparathyroidism , hyperthyroidism History Osteomalacia Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Corticosteroid induce osteoporosis</keyword>
	<keyword>prevention</keyword>
	<keyword>treatment</keyword>
	<keyword>zoledronic acid</keyword>
</DOC>